US Removes Chinese Biotech Giant from Blacklist After Court Ruling
The US government has unexpectedly removed Chinese biotechnology company WuXi AppTec from its blacklist. The Pentagon announced the removal, which was approved by the US Deputy Secretary of Defence, after a federal court barred the company’s designation.
WuXi AppTec had sued the Pentagon over its inclusion on the list, arguing that the decision was arbitrary and not based on facts.
“[The designation] was the result of political pressure,” WuXi said in its lawsuit, as quoted by Reuters on Tuesday (10 November 2026).
WuXi also welcomed the court’s decision. In a statement to the Hong Kong Stock Exchange, the company said the ruling frees it from the negative consequences of being listed under Section 1260H, which forms part of US defence legislation.
The company said it would continue serving its customers and supplying medicines that can save patients’ lives.
“We are committed to serving our customers and supporting the provision of medicines that can save lives and improve patients’ quality of life,” WuXi’s management said.
The Pentagon expanded its list of companies suspected of having links to China’s military on 8 June 2026. At least 188 entities were added, up from 130 companies the previous year.
Major names included Alibaba, BYD and Baidu. The three were linked to China’s Ministry of Industry and Information Technology.
Being placed on the blacklist does not automatically halt a company’s business activities in the US. Instead, it bars the company from entering into defence cooperation contracts with the US government.
Source: jawawa.id (https://jawawa.id/newsitem/us-removes-chinese-biotech-giant-from-blacklist-after-court-ruling-1794322222)
Originally published by CNBC Indonesia (https://www.cnbcindonesia.com/tech/20261110160542-37-783967/amerika-akhirnya-menyerah-hapus-raksasa-china-dari-daftar-hitam), translated from Indonesian